These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2858077)

  • 21. Physical dependence in baboons chronically treated with low and high doses of diazepam.
    Kaminski BJ; Sannerud CA; Weerts EM; Lamb RJ; Griffiths RR
    Behav Pharmacol; 2003 Jul; 14(4):331-42. PubMed ID: 12838039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Down-regulation of benzodiazepine binding to alpha 5 subunit-containing gamma-aminobutyric Acid(A) receptors in tolerant rat brain indicates particular involvement of the hippocampal CA1 region.
    Li M; Szabo A; Rosenberg HC
    J Pharmacol Exp Ther; 2000 Nov; 295(2):689-96. PubMed ID: 11046107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Benzodiazepine dependence and its treatment with low dose flumazenil.
    Hood SD; Norman A; Hince DA; Melichar JK; Hulse GK
    Br J Clin Pharmacol; 2014 Feb; 77(2):285-94. PubMed ID: 23126253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential expression of benzodiazepine anticonvulsant cross-tolerance according to time following flurazepam or diazepam treatment.
    Rosenberg HC
    Pharmacol Biochem Behav; 1995; 51(2-3):363-8. PubMed ID: 7667354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Precipitated withdrawal by a benzodiazepine receptor antagonist (Ro 15-1788) after 7 days of diazepam.
    Lukas SE; Griffiths RR
    Science; 1982 Sep; 217(4565):1161-3. PubMed ID: 6287579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benzodiazepine--specific and nonspecific tolerance following chronic flurazepam treatment.
    Rosenberg HC; Smith S; Chiu TH
    Life Sci; 1983 Jan; 32(3):279-85. PubMed ID: 6296589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Substantia nigra: the involvement of central and peripheral benzodiazepine receptors in physical dependence on diazepam as evidenced by behavioral and EEG effects.
    Wala EP; Sloan JW; Jing X
    Pharmacol Biochem Behav; 1999 Nov; 64(3):611-23. PubMed ID: 10548279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benzodiazepine antagonist, CGS-8216, in diazepam- or pentobarbital-dependent and non-dependent rats.
    McNicholas LF; Martin WR
    Drug Alcohol Depend; 1986 Jul; 17(4):339-48. PubMed ID: 3093182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benzodiazepine dependence: from neural circuits to gene expression.
    Pratt JA; Brett RR; Laurie DJ
    Pharmacol Biochem Behav; 1998 Apr; 59(4):925-34. PubMed ID: 9586850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacologic aspects of benzodiazepine tolerance and dependence.
    Busto U; Sellers EM
    J Subst Abuse Treat; 1991; 8(1-2):29-33. PubMed ID: 1675689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sedative-hypnotic properties of a new benzodiazepine in comparison with flurazepam. Pharmacological and clinical findings.
    Babbini M; Torrielli MV; Strumia E; Gaiardi M; Bartoletti M; De Marchi F
    Arzneimittelforschung; 1975 Aug; 25(8):1294-1300. PubMed ID: 241364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effects of the benzodiazepine antagonist Ro 15-1788 after "general anaesthetic" doses of benzodiazepines in mice.
    Little HJ; Bichard AR
    Br J Anaesth; 1984 Oct; 56(10):1153-60. PubMed ID: 6148095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The abstinence syndrome in diazepam-dependent cats is precipitated by Ro 15-1788 and Ro 15-4513 but not by the benzodiazepine receptor antagonist ZK 93426.
    Giorgi O; Corda MG; Fernández A; Biggio G
    Neurosci Lett; 1988 May; 88(2):206-10. PubMed ID: 2837694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The benzodiazepines: anxiolytic and withdrawal effects.
    Little HJ
    Neuropeptides; 1991 Jul; 19 Suppl():11-4. PubMed ID: 1679209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Benzodiazepine inhibition of adenosine uptake is not prevented by benzodiazepine antagonists.
    Morgan PF; Lloyd HG; Stone TW
    Eur J Pharmacol; 1983 Jan; 87(1):121-6. PubMed ID: 6404638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic benzodiazepine treatment increases the effects of the inverse agonist FG7142.
    Little HJ; Gale R; Sellars N; Nutt DJ; Taylor SC
    Neuropharmacology; 1988 Apr; 27(4):383-9. PubMed ID: 2901672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of the chronic dose of diazepam on the intensity and characteristics of the precipitated abstinence syndrome in the dog.
    Sloan JW; Martin WR; Wala E
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1152-62. PubMed ID: 8510000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Electroencephalographic study of Sch 161 (quazepam), a new benzodiazepine hypnotic, in rats and rabbits].
    Kawasaki H; Urabe M; Nuki C; Yamamoto R; Takasaki K; Ohno H
    Nihon Yakurigaku Zasshi; 1987 Oct; 90(4):221-38. PubMed ID: 3428780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The benzodiazepine antagonist, Ro 15-1788, prevents the effects of flurazepam on the high pressure neurological syndrome.
    Bichard AR; Little HJ
    Neuropharmacology; 1982 Sep; 21(9):877-80. PubMed ID: 6815548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anxiolytics and sedative/hypnotics dependence.
    Busto UE; Sellers EM
    Br J Addict; 1991 Dec; 86(12):1647-52. PubMed ID: 1686199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.